Treatment Outcome
50 researchers across 3 institutions
Researchers investigate the effectiveness of medical interventions and therapeutic strategies across a range of health conditions. This work involves analyzing patient data to understand how different treatments impact health outcomes, disease progression, and quality of life. Methodologies include retrospective analyses of electronic health records, clinical trial data, and patient registries. Specific areas of focus often include the efficacy of treatments for chronic diseases, the impact of surgical procedures, and the long-term effects of pharmaceutical interventions.
This research is particularly relevant to Arkansas, addressing the health needs of diverse populations and contributing to the state's growing healthcare sector. Understanding treatment outcomes can inform public health initiatives aimed at improving health equity and managing prevalent conditions within the state. Studies may explore how socioeconomic factors, prevalent in certain Arkansas communities, influence treatment adherence and results, thereby guiding the development of more accessible and effective care models.
This field draws on expertise from biostatistics, epidemiology, and health services research. Engagement spans multiple institutions across Arkansas, fostering a collaborative environment for advancing patient care and health outcomes.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Gresham Thomas Richter | UAMS | 38 | 4,567 | High Impact | |
| Jorge Saucedo | UAMS | 36 | 6,209 | ||
| John L. Dornhoffer | UAMS | 35 | 4,275 | High Impact | |
| John Paul Mounsey | UAMS | 34 | 3,257 | High Impact | |
| Sumant Inamdar | UAMS | 26 | 4,901 | Faculty | |
| Samuel C. Overley | UAMS | 24 | 2,010 | Faculty | High Impact |
| Sabha Bhatti | UAMS | 23 | 1,764 | High Impact | |
| Srikanth Vallurupalli | UAMS | 22 | 2,618 | Faculty | High Impact |
| Félix Ignacio Téllez-Ávila | UAMS | 22 | 2,426 | High Impact | |
| David B. Bumpass | UAMS | 21 | 1,678 | Faculty | High Impact |
| Hakan Paydak | UAMS | 20 | 2,283 | Faculty | High Impact |
| Michael Luna | UAMS | 19 | 1,264 | Faculty | |
| Nikhil K Meena | UAMS | 18 | 920 | Faculty | |
| Ali Tourchi | UAMS | 16 | 790 | ||
| Tomas Jandik | University of Arkansas | 15 | 1,480 | ||
| Johnathan H. Goree | UAMS | 15 | 1,188 | Faculty | |
| Milan Patel | Arkansas State University | 15 | 974 | Faculty | |
| Paul M. Seib | UAMS | 14 | 730 | Faculty | |
| Mohammad Alomari | UAMS | 13 | 590 | ||
| Larry D. Hartzell | UAMS | 12 | 436 | Faculty |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Mayo Clinic 1,772
- 2 Mayo Clinic in Arizona 1,583
- 3 Boston University 1,086
- 4 Mayo Clinic in Florida 894
- 5 Amyloidosis Foundation 873
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Treatment Outcome.